Vaughan David Investments’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.75M Sell
24,421
-213,140
-90% -$20.1M 0.03% 135
2026
Q1
$28.1M Buy
237,561
+20,243
+9% +$2.5M 0.59% 85
2025
Q4
$27.3M Buy
217,318
+7,472
+4% +$975K 0.59% 81
2025
Q3
$30.7M Buy
209,846
+6,325
+3% +$956K 0.66% 79
2025
Q2
$31.7M Buy
203,521
+22
+0% +$3.49K 0.71% 77
2025
Q1
$33.5M Buy
203,499
+6,185
+3% +$1.03M 0.78% 72
2024
Q4
$32.1M Buy
197,314
+1,330
+0.7% +$238K 0.76% 76
2024
Q3
$38.3M Buy
+195,984
New +$36.1M 0.88% 64

Other funds holding ZTS

Vaughan David Investments's ZTS Position: Q2 2026 in Review

Vaughan David Investments reduced its Zoetis (ZTS) stake by 90% in Q2 2026, selling an estimated $20.1M and leaving 24,421 shares worth $1.75M. The position accounts for 0.03% of the portfolio, ranked #135.

Vaughan David Investments first reported a position in ZTS in Q3 2024 and has held it in 8 quarters since. The position peaked at $38.3M in Q3 2024. 1,427 funds tracked by Wall St. Rank hold ZTS as of Q2 2026.

  • Vaughan David Investments held 24,421 shares of Zoetis worth $1.75M as of Q2 2026.
  • Vaughan David Investments sold 213,140 Zoetis shares in Q2 2026, an estimated $20.1M.
  • Zoetis made up 0.03% of Vaughan David Investments's portfolio in Q2 2026, its #135 holding.
  • Vaughan David Investments first reported a position in Zoetis in Q3 2024 and has held it in 8 quarters since.
  • Vaughan David Investments's Zoetis position peaked at $38.3M in Q3 2024.
  • 1,427 funds tracked by Wall St. Rank held Zoetis as of Q2 2026.

Based on Vaughan David Investments's 13F filing for Q2 2026, filed 11 Aug 2026.